Effects of Dried Onion Powder and Quercetin on Obesity-Associated Hepatic Menifestation and Retinopathy

Int J Mol Sci. 2022 Sep 21;23(19):11091. doi: 10.3390/ijms231911091.

Abstract

Onion (Allium cepa L.), rich in flavonoids (particularly quercetin), reportedly has anti-obesity properties, but the underlying mechanisms and associated health issues remain unclear. In this study, we compared the effects of dried onion powder (DO) with that of quercetin on high-fat diet (HFD)-induced obesity, nonalcoholic fatty liver disease, and retinal neovascularization. Briefly, rats (n = 9-10 per group) were divided into control, HFD alone (43% fat), HFD + DO (1% DO), HFD + 5DO (5% DO, w/w), and HFD + quercetin (180 mg/kg). After 12 weeks, body fat, markers of metabolism, fatty liver, steatohepatitis, and retinopathy were analyzed. The results revealed that DO and 5DO dose-dependently suppressed body weight, visceral and subcutaneous fat accumulation, and epididymal adipocyte in HFD-fed rats. DO also decreased HFD-induced ALT, AST, free fatty acid, glucose, proinflammatory cytokines, and oxidative stress. DO and 5DO groups had lower triglycerides, total cholesterol, proinflammatory cytokine levels, and ACC-α (a fatty acid synthesis-associated enzyme) expression but higher hepatic antioxidant enzyme activities and fecal lipids. 5DO exhibited better or similar efficacy to quercetin. Both 5DO and quercetin increased fecal levels of acetic acid and butyric acid similarly. They also reduced lipid peroxidation of the eye, retinal adiposity, and neovascularization. However, quercetin resulted in a more apparent decrease in regulation of the Raf/MAPK pathway than DO in eye specimens. Conclusively, DO suppresses visceral, subcutaneous, and liver fat accumulation better than quercetin likely due to higher fecal fat excretion and lower oxidative stress, proinflammatory cytokine levels, and ACC-α expression. Quercetin regulating signal pathways is better than DO at reducing retinal adiposity and neovascularization.

Keywords: dried onion powder; high-fat diet; obesity; quercetin; retinopathy.

MeSH terms

  • Animals
  • Antioxidants / metabolism
  • Antioxidants / pharmacology
  • Butyric Acid / pharmacology
  • Cholesterol / metabolism
  • Cytokines / metabolism
  • Diet, High-Fat / adverse effects
  • Fatty Acids, Nonesterified / metabolism
  • Glucose / metabolism
  • Liver / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Non-alcoholic Fatty Liver Disease* / metabolism
  • Obesity / drug therapy
  • Obesity / etiology
  • Obesity / metabolism
  • Onions
  • Powders / pharmacology
  • Quercetin / metabolism
  • Quercetin / pharmacology
  • Quercetin / therapeutic use
  • Rats
  • Retinal Diseases* / metabolism
  • Triglycerides / metabolism

Substances

  • Antioxidants
  • Cytokines
  • Fatty Acids, Nonesterified
  • Powders
  • Triglycerides
  • Butyric Acid
  • Cholesterol
  • Quercetin
  • Glucose